Eksempler på bruk av Studied in patients på Engelsk og deres oversettelse til Norsk
{-}
-
Colloquial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Simponi has not been studied in patients with CHF.
The use of Protopic ointment under occlusion has not been studied in patients.
Axitinib has not been studied in patients< 18 years of age.
Efficacy and safety of Renagel has not been studied in patients with.
TORISEL has not been studied in patients undergoing haemodialysis.
Folk oversetter også
The pharmacokinetics of abacavir has not been studied in patients over 65 years of age.
OZURDEX has not been studied in patients with macular oedema secondary to RVO with significant retinal ischemia.
The pharmacokinetics of rilpivirine have not been studied in patients with renal insufficiency.
SIRTURO has not been studied in patients with severe hepatic impairment and is not recommended in this population.
Ritonavir pharmacokinetic parameters have not been studied in patients with renal impairment.
Possia has not been studied in patients with moderate or severe hepatic impairment.
The activity of methylnaltrexone bromide has been studied in patients with constipation induced by opioids.
Preotact has been studied in patients with pre-existing hypercalciuria.
Duloxetine has not been studied in patients under the age of 7.
Soliris has not been studied in patients with PNH who weigh less than 40kg.
However, crizotinib has not been studied in patients with hepatic impairment.
Belatacept has not been studied in patients with Panel Reactive Antibody(PRA)> 30% who often require increased immunosuppression.
The pharmacokinetics of emtricitabine have not been studied in patients with varying degrees of hepatic insufficiency.
Idelalisib has not been studied in patients with chronic active hepatitis including viral hepatitis.
Visudyne has not been studied in patients with renal impairment.
Panobinostat has not been studied in patients with end-stage renal disease(ESRD) or patients on dialysis(see section 5.2).
FORSTEO has not been studied in patients with active urolithiasis.
Cobicistat has not been studied in patients with severe hepatic impairment and is not recommended in these patients. .
Tarceva has not been studied in patients under the age of 18 years.
AZOPT has not been studied in patients wearing contact lenses.
Eviplera has not been studied in patients over the age of 65 years.
Tolvaptan has not been studied in patients with severe renal failure.
Nelarabine has not been studied in patients with hepatic impairment.
Cerdelga has not been studied in patients with hepatic impairment.
Constella has not been studied in patients who have hepatic impairment.